GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (NSE:ALBERTDAVD) » Definitions » Cyclically Adjusted Revenue per Share

Albert David (NSE:ALBERTDAVD) Cyclically Adjusted Revenue per Share : ₹690.84 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Albert David Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Albert David's adjusted revenue per share for the three months ended in Mar. 2025 was ₹131.208. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹690.84 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Albert David's average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Albert David was 2.20% per year. The lowest was 0.70% per year. And the median was 1.45% per year.

As of today (2025-06-03), Albert David's current stock price is ₹806.35. Albert David's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹690.84. Albert David's Cyclically Adjusted PS Ratio of today is 1.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Albert David was 2.29. The lowest was 0.57. And the median was 0.87.


Albert David Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Albert David's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David Cyclically Adjusted Revenue per Share Chart

Albert David Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 659.22 677.53 697.74 705.40 690.84

Albert David Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 705.40 705.74 714.16 704.73 690.84

Competitive Comparison of Albert David's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Albert David's Cyclically Adjusted PS Ratio falls into.


;
;

Albert David Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Albert David's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=131.208/157.5517*157.5517
=131.208

Current CPI (Mar. 2025) = 157.5517.

Albert David Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 148.755 99.841 234.740
201509 172.263 101.753 266.727
201512 128.100 102.901 196.134
201603 121.355 102.518 186.500
201606 139.615 105.961 207.591
201609 159.500 105.961 237.158
201612 102.932 105.196 154.161
201703 122.566 105.196 183.567
201706 95.772 107.109 140.876
201709 160.012 109.021 231.240
201712 130.744 109.404 188.283
201803 121.086 109.786 173.767
201806 165.457 111.317 234.179
201809 136.001 115.142 186.094
201812 134.829 115.142 184.490
201903 111.326 118.202 148.387
201906 160.544 120.880 209.249
201909 156.993 123.175 200.808
201912 139.354 126.235 173.925
202003 101.035 124.705 127.647
202006 94.134 127.000 116.779
202009 125.613 130.118 152.097
202012 114.388 130.889 137.689
202103 97.445 131.771 116.510
202106 142.083 134.084 166.950
202109 151.259 135.847 175.426
202112 125.655 138.161 143.291
202203 128.441 138.822 145.770
202206 163.504 142.347 180.968
202209 161.895 144.661 176.321
202212 130.662 145.763 141.230
202303 139.942 146.865 150.125
202306 161.113 150.280 168.909
202309 163.266 151.492 169.797
202312 154.689 152.924 159.370
202403 156.077 153.035 160.684
202406 156.573 155.789 158.345
202409 172.512 157.882 172.151
202412 145.581 158.323 144.872
202503 131.208 157.552 131.208

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Albert David  (NSE:ALBERTDAVD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Albert David's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=806.35/690.84
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Albert David was 2.29. The lowest was 0.57. And the median was 0.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Albert David Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Albert David's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David Business Description

Industry
Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David Headlines

No Headlines